ORIENTBIO, Inc. (002630) Price & Analysis

― Followers

002630 Stock Chart & Stats

₩911.00

-₩68.00(-6.95%)

Jul 28, 2026

―

Day’s Range― - ―

52-Week Range₩745.00 - ₩1,632.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)506.98K

Market Cap

₩58.03B

Enterprise ValueN/A

Total Cash (Recent Filing)₩32.77B

Total Debt (Recent Filing)₩1.94B

Price to Earnings (P/E)―

Beta0.01

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-76.76

Shares Outstanding59,291,504

10 Day Avg. Volume561,623

30 Day Avg. Volume506,980

Financial Highlights & Ratios

PEG Ratio0.23

Price to Book (P/B)1.00

Price to Sales (P/S)2.30

P/FCF Ratio125.11

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

002630 FAQ

What was ORIENTBIO, Inc.’s price range in the past 12 months?

ORIENTBIO, Inc. lowest stock price was ₩745.00 and its highest was ₩1632.00 in the past 12 months.

What is ORIENTBIO, Inc.’s market cap?

ORIENTBIO, Inc.’s market cap is ₩58.03B.

When is ORIENTBIO, Inc.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were ORIENTBIO, Inc.’s earnings last quarter?

ORIENTBIO, Inc. released its earnings results on Jun 19, 2026. The company reported -₩7.839 earnings per share for the quarter, missing the consensus estimate of N/A by -₩7.839.

Is ORIENTBIO, Inc. overvalued?

According to Wall Street analysts ORIENTBIO, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does ORIENTBIO, Inc. pay dividends?

ORIENTBIO, Inc. does not currently pay dividends.

What is ORIENTBIO, Inc.’s EPS estimate?

ORIENTBIO, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does ORIENTBIO, Inc. have?

ORIENTBIO, Inc. has 59,291,504 shares outstanding.

What happened to ORIENTBIO, Inc.’s price movement after its last earnings report?

ORIENTBIO, Inc. reported an EPS of -₩7.839 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.213%.

Which hedge fund is a major shareholder of ORIENTBIO, Inc.?

Currently, no hedge funds are holding shares in KR:002630

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

ORIENTBIO, Inc.

ORIENT BIO Inc. is a South Korean company active within the biotechnology sector. The firm specializes in providing laboratory animals and a range of equipment tailored for research environments. Established in 1959, the company initially operated as Orient Co., Ltd. before being rebranded as ORIENT BIO Inc. in 2005. Its operations are headquartered in Seongnam, South Korea.